Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, as he discusses a recent article in The Journal of Clinical Endocrinology & Metabolism with Katie Guttenberg, MD, from University of Texas Health at Houston and Maria Fleseriu, MD, director of the NW Pituitary Center at Oregon Health & Science University. The article, by Gadelha et al, is from the July 2022 edition of JCEM: “Randomized Trial of Osilodrostat for the Treatment of Cushing Disease.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related